DWS & Huntsman Form Cooperation to Bring New IROPRINT™ Resin For SLA Printing to Market

Visit both companies at Formnext from 19 to 22 November 2019, Frankfurt, Germany
Find DWS at Booth C31 in Hall 12.1 & Huntsman at Booth F20 in Hall 11.1

November 19, 2019 – DWS, a respected pioneer and technology leader in precision stereolithography (SLA) systems and 3D printing materials, has forged a strategic cooperation with global chemical company Huntsman. The collaboration will give footwear companies, and other industrial manufacturers, access to the SLA 3D printing of a new kind of polyurethane-based resin, which is soft, flexible, easy to print, and can be readily adopted into manufacturing environments.

IROPRINTTM R 1801 resin is a radiation cured, one-component polyurethane resin. Developed by Huntsman, the resin delivers the right combination of elasticity and strength alongside an excellent resolution, high quality surface – and can be used to make footwear components, sports equipment and other products that need to have the look and feel of rubber.

DWS worked closely with Huntsman during the development of IROPRINTTM R 1801 resin to ensure that the resulting material was optimized for SLA printing. DWS shared its vast experience in the development of SLA 3D printing systems, which are capable of delivering highly smooth and detailed surfaces and shapes, without the need for long and costly curing processes after printing; while Huntsman shared its technology leadership in UV cured polyurethane technology.

Maurizio Costabeber, Chief Technology Officer at DWS, said: “With the development of IROPRINTTM R 1801 resin for SLA, DWS and Huntsman have created a manufacturing solution that will help ease the adoption of 3D printing processes into the manufacturing environment for the creation of a multitude of industrial, rubber-like products, including, specifically, footwear and sports equipment. As a well-established player in SLA, we produce a large range of our own materials for 3D printing. Working with Huntsman, though, we sped up the development of a joint solution, which avoids the post processing complexities of other existing methods, while delivering – at the same time – the desired result in terms of surface quality and definition on finished products.”

Stephane Peysson, Global Business Development Manager at Huntsman, said: “This announcement is the culmination of more than two years of close cooperation between DWS and Huntsman - and is our first collaboration in the field of radiation curing 3D printing. This is also the first time that DWS has teamed up with a major polyurethane provider, taking advantage of our world-class equipment, technology and people. As we build our 3D printing ecosystem, we are delighted to have the opportunity to work with DWS, a highly innovative, pragmatic and focused company. Working together with DWS was really easy. As organizations, we are very similar. Both companies have strong links to the families that founded them, and are entrepreneurial and flexible. Crucially, we are also both aligned in our commitment to furthering the adoption of 3D printing in mass manufacturing.”

Manufacturers of footwear, sports equipment and other rubber-like products are invited to find out more about the cooperation between DWS and Huntsman at Formnext – where both companies are exhibiting and where printers and materials will be in action. Visit DWS at Booth C31 Hall 12.1 and Huntsman at Booth F20 in Hall 11.1. Formnext runs from November 19-22, 2019 in Frankfurt, Germany.


IROPRINTTM is a trademark of Huntsman Corporation or an affiliate thereof in one or more, but not all, countries.



About DWS:
DWS is very much at the forefront of additive manufacturing technology. A respected stereolithography pioneer and leader, DWS is making additive manufacturing 4.0 real, by delivering the most advanced photopolymer additive manufacturing systems, materials and digital tools available. For decades, DWS has been enabling people to live better, by allowing engineers to optimize their designs and companies to bring better products to market. Read more at:

Social Media:
Instagram: www.instagram.com/dwssystems

About Huntsman:
Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals with 2018 revenues more than $9 billion. Our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. We operate more than 75 manufacturing, R&D and operations facilities in approximately 30 countries and employ approximately 10,000 associates within our four distinct business divisions. For more information about Huntsman, please visit the company's website at

Social Media:
Facebook: www.facebook.com/huntsmancorp
LinkedIn: www.linkedin.com/company/huntsman

Forward-Looking Statements:
Certain information in this release constitutes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current beliefs and expectations. The forward-looking statements in this release are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the company's operations, markets, products, services, prices and other factors as discussed under the caption "Risk Factors" in the Huntsman companies' filings with the U.S. Securities and Exchange Commission. Significant risks and uncertainties may relate to, but are not limited to, volatile global economic conditions, cyclical and volatile product markets, disruptions in production at manufacturing facilities, reorganization or restructuring of Huntsman's operations, including any delay of, or other negative developments affecting the ability to implement cost reductions and manufacturing optimization improvements in Huntsman businesses and realize anticipated cost savings, and other financial, economic, competitive, environmental, political, legal, regulatory and technological factors. The company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by applicable laws.

Ilse Vanden Brande